RELAY THERAPEUTICS INC's ticker is RLAY and the CUSIP is 75943R102. A total of 3 filers reported holding RELAY THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $127,000 | +7.6% | 15,158 | +60.9% | 0.00% | – |
| Q2 2023 | $118,000 | +49.4% | 9,420 | +95.5% | 0.00% | – |
| Q1 2023 | $79,000 | -63.4% | 4,818 | -66.7% | 0.00% | – |
| Q4 2022 | $216,000 | +644.8% | 14,450 | +1022.8% | 0.00% | – |
| Q3 2022 | $29,000 | +314.3% | 1,287 | +198.6% | 0.00% | – |
| Q2 2022 | $7,000 | -94.6% | 431 | -90.0% | 0.00% | – |
| Q1 2022 | $129,000 | -86.3% | 4,299 | -86.0% | 0.00% | – |
| Q4 2021 | $944,000 | +56.0% | 30,728 | +60.5% | 0.00% | – |
| Q3 2021 | $605,000 | +298.0% | 19,150 | +361.1% | 0.00% | – |
| Q2 2021 | $152,000 | +16.9% | 4,153 | +10.3% | 0.00% | – |
| Q1 2021 | $130,000 | +828.6% | 3,765 | +997.7% | 0.00% | – |
| Q4 2020 | $14,000 | +1300.0% | 343 | +1082.8% | 0.00% | – |
| Q3 2020 | $1,000 | – | 29 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management IV, LLC | 2,139,380 | $73,958,000 | 8.86% |
| Darwin Global Management, Ltd. | 782,471 | $27,050,000 | 5.30% |
| EcoR1 Capital, LLC | 3,429,363 | $118,553,000 | 5.26% |
| Foresite Capital Management V, LLC | 400,000 | $13,828,000 | 4.06% |
| Grace Capital | 183,112 | $6,330,000 | 4.03% |
| BVF INC/IL | 2,873,147 | $99,325,000 | 3.72% |
| Casdin Capital, LLC | 3,375,058 | $116,676,000 | 3.48% |
| Fernwood Investment Management, LLC | 185,063 | $6,398,000 | 2.35% |
| Alphabet Inc. | 1,568,486 | $54,222,000 | 2.19% |
| SB INVESTMENT ADVISERS (UK) LTD | 27,904,963 | $964,675,000 | 1.67% |